New capability embeds a secure, zero-trust database interface directly into the Keeper Vault, eliminating exposed credentials, unmanaged tools and insecure access paths Keeper Security, the leading ...
The EMA has started its review of Daiichi Sankyo and AstraZeneca's Enhertu as a first-line therapy for HER2-positive breast cancer, setting up a possible approval later this year. The two companies ...
Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...
Several others were injured in the Iranian attack that was the first to kill Palestinians in the Israeli-occupied West Bank ...
The U.S. Embassy in Baghdad urged all American citizens to leave Iraq immediately on Saturday after the embassy was attacked ...
Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater State University and helps develop content strategies. A letter of intent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results